Acetazolamide

Generic Name
Acetazolamide
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C4H6N4O3S2
CAS Number
59-66-5
Unique Ingredient Identifier
O3FX965V0I
Background

One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of...

Indication

For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma

Associated Conditions
Acute angle-closure glaucoma, Edema, Familial periodic paralysis, Generalized Tonic-Clonic Seizures, Metabolic Alkalosis, Open Angle Glaucoma (OAG), Other and unspecified effects of high altitude, Cystine renal calculi, Drug-induced edema, Nonuveitic secondary glaucoma, Salicylate intoxication
Associated Therapies
Urine alkalinization therapy

Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients

First Posted Date
2024-08-02
Last Posted Date
2024-08-05
Lead Sponsor
Helwan University
Target Recruit Count
60
Registration Number
NCT06535529
Locations
🇪🇬

Critical Care Medicine Department - Cairo University Hospitals., Cairo, Egypt

Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder

First Posted Date
2024-07-26
Last Posted Date
2024-08-27
Lead Sponsor
Sanjay R Patel
Target Recruit Count
40
Registration Number
NCT06521476
Locations
🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2024-07-12
Last Posted Date
2024-07-12
Lead Sponsor
University of Zurich
Target Recruit Count
270
Registration Number
NCT06498505
Locations
🇰🇬

National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2024-07-12
Last Posted Date
2024-07-12
Lead Sponsor
University of Zurich
Target Recruit Count
270
Registration Number
NCT06499727
Locations
🇰🇬

National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2024-07-12
Last Posted Date
2024-07-12
Lead Sponsor
University of Zurich
Target Recruit Count
270
Registration Number
NCT06498531
Locations
🇰🇬

National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload

First Posted Date
2024-05-16
Last Posted Date
2024-07-24
Lead Sponsor
Cairo University
Target Recruit Count
110
Registration Number
NCT06414759
Locations
🇪🇬

National Heart Institute, Giza, GZ, Egypt

Optimal Diuretic Therapies for Acute Heart Failure with Volume Overload

First Posted Date
2023-12-12
Last Posted Date
2024-12-17
Lead Sponsor
Johannes Grand
Target Recruit Count
939
Registration Number
NCT06166654
Locations
🇩🇰

Bispebjerg Hospital, Copenhagen, Denmark

🇩🇰

Herlev-Gentofte hospital, Copenhagen, Denmark

🇩🇰

Amager-Hvidovre Hospital, Hvidovre, Capital Region of Denmark, Denmark

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients with OSA

First Posted Date
2023-11-24
Last Posted Date
2024-12-02
Lead Sponsor
Incannex Healthcare Ltd
Target Recruit Count
560
Registration Number
NCT06146101
Locations
🇺🇸

Desert Center for Allergy and Chest Diseases, Pheonix, Arizona, United States

🇺🇸

Exalt Clinical Research, Chula Vista, California, United States

🇺🇸

CenExel CNS- Los Alamitos, Long Beach, California, United States

and more 19 locations

The AXIS Study: the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2023-11-02
Last Posted Date
2024-12-06
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Target Recruit Count
19
Registration Number
NCT06114537
Locations
🇳🇱

Amsterdam University Medical Centers, Amsterdam, Noord-Holland, Netherlands

Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda Consumption

Early Phase 1
Conditions
Interventions
First Posted Date
2023-10-31
Last Posted Date
2024-05-07
Lead Sponsor
University of Arizona
Target Recruit Count
44
Registration Number
NCT06110078
Locations
🇺🇸

College of Medicine Phoenix U of Arizona, Phoenix, Arizona, United States

© Copyright 2024. All Rights Reserved by MedPath